CGAS and Axenfeld-Rieger syndrome: Experiments have confirmed that the VDAC1 inhibitor DIDS and cGAS inhibitors can alleviate radiation‐induced depletion of bone marrow stem cells and abnormal infiltration of macrophages (F4/80+), providing a new strategy for the prevention and treatment of ARS by targeting the mitochondria–cGAS pathway [111].